Molecular Characterization of Malignant Pleural Mesothelioma (MPM) by next Generation Sequencing

被引：0
|
作者：
Cedres, Susana [1 ]
De Castro, Am Martinez [1 ]
Pardo, Nuria [1 ]
Navarro, Alejandro [1 ]
Martinez, Alex [1 ]
Amair, Fabiola [1 ]
Racca, Fabricio [1 ]
Scheenaard, Eulalia [2 ]
Recasens, Sergi [2 ]
De la Fuente, Iris [2 ]
Retter, Andrea [2 ]
Vilaro, Marta [2 ]
Vivancos, Ana [2 ]
Felip, Enriqueta [1 ]
机构：
[1] Vall Dhebron Univ Hosp, Vall Dhebron Inst Oncol, Med Oncol, Barcelona, Spain
[2] Vall Dhebron Inst Oncol, Med Oncol, Barcelona, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
malignant pleural mesothelioma; next generation sequencing;
D O I：
10.1016/j.jtho.2016.11.1918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-019
引用
收藏
页码：S1355 / S1356
页数：2
相关论文
共 50 条
  • [31] Characterization of the effect of pleurodesis on FLT and FDG PET/CT imaging in malignant pleural mesothelioma (MPM)
    Francis, Roslyn
    Nowak, Anna
    Segard, Tatiana
    Morandeau, Laurence
    Lee, Gary
    Boucek, Jan
    Millward, Michael
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [32] The TCGA malignant pleural mesothelioma (MPM) project: VISTA expression and delineation of a novel clinical-molecular subtype of MPM.
    Ladanyi, Marc
    Robinson, Bruce W. S.
    Campbell, Peter J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] A Comprehensive Genome-Based Mutational Analysis by Next Generation Sequencing Technology in Patients With Malignant Pleural and Peritoneal Mesothelioma
    Ugurluer, G.
    Chang, K.
    Mayeda, M.
    Gamez, M. E.
    Arnett, A. L. H.
    Jayakrishnan, R.
    Anderson, B.
    Sio, T. T. W.
    Miller, R. C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S185 - S186
  • [34] A Retrospective Evaluation of 64 Hospitalised Malignant Pleural Mesothelioma (MPM) Patients
    Ustamujic, Aida
    Cukic, Vesna
    Catovic-Pecanac, Elmedina
    Dizdarevic-Spago, Dina
    Sladic, Irma
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1381 - S1381
  • [35] SOLUBLE MESOTHELIN RELATED PROTEIN (SMRP) IN MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Azim, H. A., Jr.
    Gaafar, R.
    Abdelsalam, I.
    Khorshid, O.
    Elguindi, S.
    Elattar, I.
    Ashmawy, A.
    [J]. LUNG CANCER, 2009, 64 : S66 - S66
  • [36] LACK OF RESPONSE TO CHEMOTHERAPY FOR PREVIOUSLY TREATED MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S638 - S639
  • [37] INCIDENCE, PREVALENCE, AND SURVIVAL OF MALIGNANT PLEURAL MESOTHELIOMA (MPM) IN THE UNITED STATES
    Kim, A.
    Wong, W.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A95 - A95
  • [38] The role of VATS decortication in the therapeutic management of malignant pleural mesothelioma (MPM)
    Nakas, A.
    Chamberlain, M. H.
    Ucar, A. E. Martin
    Edwards, J. G.
    Waller, D. A.
    [J]. LUNG CANCER, 2007, 57 : S14 - S14
  • [39] Pemetrexed in combination with carboplatin in elderly patients with malignant pleural mesothelioma (MPM)
    Castagneto, B.
    Santoro, A.
    Ceresoli, G. L.
    Marangolo, M.
    Mencoboni, M.
    Zucali, P.
    Favaretto, A.
    Grossi, F.
    Bearz, A.
    Botta, M.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2006, 60 : S18 - S18
  • [40] MULTIMODALITY THERAPY IN MALIGNANT PLEURAL MESOTHELIOMA (MPM): SINGLE INSTITUTIONAL EXPERIENCE
    Kadota, Y.
    Yates, D. H.
    Spratt, P.
    Pendlebury, S.
    Dhital, K.
    Stone, E.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (03) : S31 - S31
12345